<DOC>
	<DOCNO>NCT02209844</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics , pharmacodynamics BI 44847</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Rising Oral Doses BI 44847 Powder Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , HR ) , 12lead ECG , clinical laboratory test 2 . Age ≥ 18 Age ≤ 50 year 3 . BMI ≥ 18.5 BMI ≤ 29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation 1 . Any finding medical examination ( include BP , pulse rate ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 5 . History relevant orthostatic hypotension , faint spell blackouts 6 . Chronic relevant acute infection 7 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 8 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 9 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 10 day prior administration trial 10 . Participation another trial investigational drug within two month prior administration trial 11 . Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) 12 . Inability refrain smoke trial day 13 . Alcohol abuse ( 60 g/day ) 14 . Drug abuse 15 . Blood donation ( 100 mL ) within four week prior administration trial 16 . Excessive physical activity ( within one week prior administration trial ) 17 . Any laboratory value outside reference range clinical relevance 18 . Inability comply dietary regimen study centre 19 . Any ECG value outside reference range clinical relevance include , limited QRS interval &gt; 120 ms. A mark baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m QT &gt; 500 m ) . 20 . A history additional risk factor Torsade de Pointes ( e.g. , heart failure , hypokalemia , family history Long QT Syndrome ) 21 . The use concomitant medication prolong QT/QTc interval 22 . Elevated urinary glucose level screen ( &gt; 15 mg/dl )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>